BIOLOGIC/DISEASE-MODIFYING ANTIRHEUMATIC DRUG
Humira is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat signs and symptoms, induce major clinical response, inhibit the progression of structural damage, and improve physical function in adults with moderately to severely active rheumatoid arthritis. Humira is also referred to by its drug name, adalimumab.
Humira is considered a biologic disease-modifying antirheumatic drug (DMARD). Humira is believed to work by inhibiting tumor necrosis factor alpha (TNF-α), a chemical messenger involved in autoimmune attacks..
How do I take it?
Humira is administered every other week by subcutaneous injection. If your doctor determines it is appropriate to do so, you may self-inject at home. Humira comes in a prefilled, single-use syringe. Your doctor will show you how to administer it.
Humira is available as a pen or prefilled syringe.
The FDA-approved label for Humira lists common side effects including infections, headache, injection site reactions, and rash.
Rare but serious side effects listed for Humira include severe infections, lymphoma and other cancers, severe allergic reactions, nerve disorders such as multiple sclerosis and Guillain-Barré syndrome, hepatitis B virus reactivation, low blood cell counts, heart failure, and lupus-like syndrome.
For more details about this treatment, visit:
Humira — AbbVie
Humira — Drugs.com